Turkey Events Eurasia Biotechnology Forum
‘Next-Generation-Sequencing’ (NGS) technology has revolutionized the way illnesses are diagnosed and treated. Today, NGS technology allows doctors to diagnose serious medical conditions before they cause harm to patients, or diagnose existing ailments with greater precision leading to better treatment.
This Forum will host various leading U.S. biotechnology companies employing NGS technologies and genetic tests that result in early detection of disease and lead to precise patient treatments.
The Forum will also provide a roadmap for countries in Eurasia to partner with U.S. companies to develop their own medical biotechnology ecosystems while ensuring their nations’ health data is kept secure.
Who Should Participate?
- Ministry of Health officials
- National biotechnology institute officials
- Genetic diagnostic lab executives
- In-vitro labs executives
- Molecular biology and genetics researchers
- Medical oncologists delivering personalized treatment for cancer
- Ob-gyns screening pregnant women
- Medical biotechnology start-ups
- Medical biotechnology clusters in universities
- Importers of in-vitro diagnostics equipment and test kits
Event Details:
Date: December 13, 2022 – Tuesday
Time: 14:00 - 17:20 Turkey time
Location: Virtual – Your Computer via Microsoft Teams
Registration: Register Here
Joining the Event: Following your registration, you will receive a calendar invite. Please accept and add it to your calendar. On the day of the Forum, please click on ‘Join Now’ button in the invite to participate.
Language: English (no interpretation provided)
Fee: No fee
For Questions:
U.S. Commercial Service Türkiye
Ebru Olcay
Ebru.Olcay@trade.gov
